Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its third quarter 2013 financial results before the market opens on Wednesday, November 6, 2013, and host a conference call shortly thereafter at 8:30 a.m. ET (Eastern Time) to discuss the results. Paul K. Wotton, Ph.D., President and Chief Executive Officer, and Robert F. Apple, EVP, Chief Financial Officer, and President of the Parenteral Products Division, will host the call.
Help employers find you! Check out all the jobs and post your resume.
